These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24675995)

  • 1. Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.
    He J; Lai H; Engle M; Gorlatov S; Gruber C; Steinkellner H; Diamond MS; Chen Q
    PLoS One; 2014; 9(3):e93541. PubMed ID: 24675995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.
    Lai H; He J; Hurtado J; Stahnke J; Fuchs A; Mehlhop E; Gorlatov S; Loos A; Diamond MS; Chen Q
    Plant Biotechnol J; 2014 Oct; 12(8):1098-107. PubMed ID: 24975464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice.
    Lai H; Engle M; Fuchs A; Keller T; Johnson S; Gorlatov S; Diamond MS; Chen Q
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2419-24. PubMed ID: 20133644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
    Wessel AW; Doyle MP; Engdahl TB; Rodriguez J; Crowe JE; Diamond MS
    mBio; 2021 Oct; 12(5):e0244021. PubMed ID: 34634945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.
    Vogt MR; Dowd KA; Engle M; Tesh RB; Johnson S; Pierson TC; Diamond MS
    J Virol; 2011 Nov; 85(22):11567-80. PubMed ID: 21917960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.
    Chung KM; Nybakken GE; Thompson BS; Engle MJ; Marri A; Fremont DH; Diamond MS
    J Virol; 2006 Feb; 80(3):1340-51. PubMed ID: 16415011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation.
    Jugler C; Joensuu J; Chen Q
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
    Lee PD; Mukherjee S; Edeling MA; Dowd KA; Austin SK; Manhart CJ; Diamond MS; Fremont DH; Pierson TC
    J Virol; 2013 Dec; 87(24):13729-40. PubMed ID: 24109224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants.
    He J; Lai H; Brock C; Chen Q
    J Biomed Biotechnol; 2012; 2012():106783. PubMed ID: 22187532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.
    Thompson BS; Moesker B; Smit JM; Wilschut J; Diamond MS; Fremont DH
    PLoS Pathog; 2009 May; 5(5):e1000453. PubMed ID: 19478866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.
    Zhang S; Vogt MR; Oliphant T; Engle M; Bovshik EI; Diamond MS; Beasley DW
    J Infect Dis; 2009 Jul; 200(2):202-5. PubMed ID: 19527169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
    Oliphant T; Engle M; Nybakken GE; Doane C; Johnson S; Huang L; Gorlatov S; Mehlhop E; Marri A; Chung KM; Ebel GD; Kramer LD; Fremont DH; Diamond MS
    Nat Med; 2005 May; 11(5):522-30. PubMed ID: 15852016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.
    Sultana H; Foellmer HG; Neelakanta G; Oliphant T; Engle M; Ledizet M; Krishnan MN; Bonafé N; Anthony KG; Marasco WA; Kaplan P; Montgomery RR; Diamond MS; Koski RA; Fikrig E
    J Immunol; 2009 Jul; 183(1):650-60. PubMed ID: 19535627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically delivered antibody protects against West Nile virus.
    Pereboev A; Borisevich V; Tsuladze G; Shakhmatov M; Hudman D; Kazachinskaia E; Razumov I; Svyatchenko V; Loktev V; Yamshchikov V
    Antiviral Res; 2008 Jan; 77(1):6-13. PubMed ID: 17904654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.
    Hofmeister Y; Planitzer CB; Farcet MR; Teschner W; Butterweck HA; Weber A; Holzer GW; Kreil TR
    J Virol; 2011 Feb; 85(4):1896-9. PubMed ID: 21123389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.